Marshall Wace North America’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-9,139
Closed -$264K 1142
2020
Q1
$264K Buy
+9,139
New +$264K ﹤0.01% 864
2017
Q3
Sell
-13,756
Closed -$674K 1232
2017
Q2
$674K Buy
+13,756
New +$674K ﹤0.01% 1034
2013
Q4
Sell
-34,687
Closed -$831K 687
2013
Q3
$831K Buy
+34,687
New +$831K 0.03% 375